2 completed, 1 active not recruiting. 3 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Active not recruiting 1 |
| Phase 3 | 3 | Completed 2, Active not recruiting 1 |
Follow Elaprase: new trials by email Literature Review of Elaprase trials Research Report on Elaprase
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Extension Study of Idursulfase-IT Along With Elaprase in Children and Adults With Hunter Syndrome and Cognitive Impairment Idursulfase-IT, Elaprase - Hunter Syndrome | Phase 2 / Phase 3 | Active not recruiting | Takeda | 6 | 2024-03-05 | 2025-11-06 |
| Study of Long Term Safety and Clinical Outcomes of Idursulfase IT and Elaprase Treatment in Pediatric Participants Who Have Completed Study HGT-HIT-094 Idursulfase-IT, Elaprase - Hunter Syndrome | Phase 2 / Phase 3 | Completed | Shire | 56 | 2015-04-14 | 2025-06-19 |
| Iduronate-2-sulfatase Enzyme Replacement Therapy in Mucopolysaccharidosis II (MPS II) Iduronate-2-sulfatase enzyme replacement therapy, iduronate-2-sulfatase enzyme replacement therapy, Placebo - Mucopolysaccharidosis II | Phase 2 / Phase 3 | Completed | Shire | 96 | 2003-09-18 | 2021-06-10 |
Mucopolysaccharidosis II (3) · Sudden Infant Death (1)
Canada (2) · France (2) · United Kingdom (2) · United States (2) · Australia (1) · Brazil (1) · Germany (1) · Mexico (1) · Spain (1)
PMID 23837440, PMID 33874971, PMID 35961250, PMID 37915038
2014 (1), 2023 (1)